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Abstract
We examined changes in zeta potential (the surface charge density, j) of the complexes of liposome (nmol)/DNA (Wg) (L/
D) formed in water at three different ratios (L/D = 1, 10 and 20) by changing the ionic strength or pH to find an optimum
formulation for in vivo gene delivery. At high DNA concentrations, j of the complexes formed in water at L/D = 10 was
significantly lowered by adding NaCl (j= +8.44 þ 3.1 to 327.6 þ 3.5 mV) or increasing pH from 5 (j= +15.3 þ 1.0) to 9
(j=322.5 þ 2.5 mV). However, the positively charged complexes formed at L/D = 20 (j= +6.2 þ 3.5 mV) became negative as
NaCl was added at alkaline pH as observed in medium (j=319.7 þ 9.9 mV). Thus, the complexes formed in water under the
optimum condition were stable and largely negatively charged at L/D = 1 (j=358.1 þ 3.9 mV), unstable and slightly
positively charged at L/D = 10 (j= +8.44 þ 3.7 mV), and unstable and largely positively charged at L/D = 20 (j= +24.3 þ 3.6
mV). The negatively charged complexes efficiently delivered DNA into both solid and ascitic tumor cells. However, the
positively charged complexes were very poor in delivering DNA into solid tumors, yet were efficient in delivering DNA into
ascitic tumors grown in the peritoneum regardless of complex size. This slightly lower gene transfer efficiency of the
negatively charged complexes can be as efficient as the positively charged ones when an injection is repeated (at least two
injections), which is the most common case for therapy regimes. The results indicate that optimum in vivo lipofection may
depend on the site of tumor growth. ß 2000 Elsevier Science B.V. All rights reserved.
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Cationic liposome-mediated transfection (lipofec-
tion) has been used as an e⁄cient method for direct
gene transfer both in vitro and in vivo, an alternative
to viral infection [1]. Cationic liposomes are made of
both cationic lipids and neutral phospholipids, con-
ferring positively charged submicrometer particles,
while plasmid DNA is a hydrophilic molecule with
a highly negative surface charge due to the presence
of phosphate groups on each nucleotide. These two
oppositely charged molecules spontaneously form
complexes when simply mixed. The structure and
function of the liposome/DNA ionic complexes
have been extensively studied. At low lipid/DNA ra-
tios, liposomes adhered to DNA as ‘beads on a
string’, while at high ratios the DNA strands either
intercalated between the lipid bilayers or are coated
by the liposomes [2^4]. These models did not support
the complex structure formed in serum-free medium,
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being all largely negatively charged (j=322.7 þ 3.6
mV) at all liposome/DNA ratios as we previously
reported [5]. This discrepancy may be due to the
solvent system that was used to prepare the com-
plexes. In this paper, we report the surface charge
density (zeta potential, j) and size (the hydrodynamic
diameter, dH) of the liposome/DNA complexes
formed in water (very low ionic strength) and their
relation to in vivo gene transfer e⁄ciency using laser
light scattering (ZetaPal, Brookhaven, New York) to
measure both j and dH. The parameters used to mea-
sure j were: zeta potential model = Smoluchowski,
¢eld frequency = 2.00 Hz, voltage = 3.00 V. The other
parameters, temperature = 25‡C unless speci¢ed, vis-
cosity = 0.0890 cP, re£ex index = 1.330, angle = 90‡,
and wavelength = 676 nm, were used for measuring
both j and dH.
The liposome/DNA complexes for in vitro trans-
fection were prepared with a small quantity of DNA
(1^5 Wg) in serum-free DMEM (calculated ionic
strength = 0.17) [6]. On the other hand, the com-
plexes for in vivo transfection were prepared with a
large quantity of DNA (30^200 Wg) in water (ionic
strength 6 0.002) which has been used to treat ovar-
ian and breast tumors grown in mice [7,8]. Lipo-
somes were composed of 3L[N-(NP,NP-dimethylami-
noethane)carbamoyl] cholesterol (DC-chol) and
dioleoylphosphatidyl ethanolamine (DOPE) (3:2 mo-
lar ratio) which were combined in chloroform, dried
thoroughly, and hydrated with deionized water (pH
7.50 þ 0.25) as previously described [9,10]. To exam-
ine the dependence of j on DNA concentration, we
determined j of the complexes formed in low and
high ionic strength at one low liposome/DNA ratio
(L/D = 1) and two high liposome/DNA ratios (L/D
= 10 and 20) at di¡erent DNA concentrations (1^
30 Wg) but keeping the liposome/DNA ratio con-
stant. In water, increasing the DNA concentration
from 1 to 30 Wg slightly changed j of the complexes,
being still positive at L/D = 10 (j= +22.7 þ 2.1 to
+8.44 þ 3.0) and L/D = 20 (j= +29.4 þ 1.7 to
+24.7 þ 3.6 mV), however, signi¢cantly decreased at
L/D = 1 from 0 þ 3.0 to 358.8 þ 2.1 mV (Fig. 1A). In
medium, increasing the DNA concentration (1^10
Wg) slightly changed j of the complexes at all ratios
(Fig. 1B). We accidentally found that j of complexes
formed at L/D = 20 decreased with the age of me-
dium. The pH of fresh medium (red color) was
+7.43 þ 0.19, while the pH of old medium (pink
color) was +8.47 þ 0.17. The complexes formed in
fresh medium were slightly positively charged
(j= +3.58 þ 4.5 to +7.56 þ 1.4 mV), while those in
old medium were largely negatively charged
(j=324.3 þ 4.8 to 318.9 þ 1.9 mV) (Fig. 1B). How-
ever, the pH of the medium did not a¡ect j of the
complexes formed at L/D = 1 and 10, being all neg-
ative (j=329.5 þ 0.2 to 314.2 þ 2.4 mV) (Fig. 1B).
Thus, in vitro and in vivo transfection e⁄ciency can
be a¡ected by the pH of the medium.
To determine an optimum formulation for in vivo
gene delivery, we examined the e¡ect of the ionic
strength and pH on j of the DNA/liposome com-
Fig. 1. j of liposome/DNA complexes formed in water (A) and in serum-free medium (B) at three di¡erent ratios. Plasmid CAT
DNA (1^30 Wg) was mixed with DC-chol liposome (10^600 nmol) in either water or medium to give L/D = 1, 10 and 20 and subject
to j measurement. The pH of water was 7.50 þ 0.25, the pH of fresh medium was 7.43 þ 0.19, while the pH of old medium (stored in
a refrigerator for at least 4^5 days) was 8.47 þ 0.17.
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plexes formed in water. The addition of NaCl in a
formulation did not signi¢cantly change the charge
of the complexes formed at L/D = 1 (j=358.2 þ 3.0
mV at [NaCl] = 0, j=351.3 þ 7.7 mV at [NaCl] =
150 mM) or at L/D = 20 (j= +18.5 þ 4.2 mV at
[NaCl] = 0, j= +24.7 þ 3.6 mV at [NaCl] = 150 mM)
(Fig. 2A). However, the charge of the complexes
formed at L/D = 10 dramatically decreased in the
presence of NaCl (j= +8.44 þ 3.1 mV at [NaCl] = 0,
j=327.6 þ 3.5 mV at [NaCl] = 10 mM or higher)
(Fig. 2A). Likewise, an increase in pH of a formula-
tion slightly changed the charge of the complexes
formed at L/D = 1 (j=362.9 þ 2.5 mV at pH 5 to
368.7 þ 1.5 mV at pH 9) or at L/D = 20 (j=
+22.5 þ 2.7 mV at pH 5 to 11.1 þ 3.9 mV at pH 9)
(Fig. 2B). These positively charged complexes formed
at L/D = 20 became negative as NaCl was added at
alkaline pH, as observed in Fig. 1B (j=319.7 þ 9.9
mV). A dramatic decrease in the charge of the com-
plexes formed at L/D = 10 was also observed as the
pH increased (j= +15.3 þ 1.0 mV at pH 5 to
322.9 þ 2.5 mV at pH 9) (Fig. 2B). We also exam-
ined the e¡ect of temperature on j. This was because
the formulation to be injected was prepared at room
temperature but in vivo gene transfer occurred at
body temperature. Unexpectedly, temperature did
not seem to a¡ect the charges of the complexes
formed at any ratio, although the complexes at
L/D = 10 were slightly negative at 37‡C (Fig. 2C).
Thus, one should be aware of a decrease in complex
charges by increasing the ionic strength and/or pH
of a formulation, when high L/D is chosen for in-
jection.
To examine the relationship between two physical
parameters and in vivo gene transfer e⁄ciency, we
performed in situ lipofection in two di¡erent types of
tumors, solid tumors grown subcutaneously and as-
citic tumors grown in the peritoneum of mice. The
complexes formed under the optimum condition (no
NaCl at neutral pH) with 30 Wg DNA and 30 nmol
of liposomes were stable and largely negatively
charged at L/D = 1, unstable and slightly positively
charged at L/D = 10, and unstable and largely posi-
tively charged at L/D = 20 (Fig. 1A and Table 1).
The complexes formed at L/D = 10 and 20 were
largely aggregated and precipitated with incubation
due to £occulation (Table 1). The negatively charged
complexes at L/D = 1 remained unchanged in size for
at least 1 week stored in a refrigerator (data not
shown). Surprisingly, their in situ lipofection activ-
ities were dependent on the type of tumor (or the site
of tumor growth). For ascitic tumors, 6^7-week-old
female C3HeFeB/J mice (Jax Lab., Bar Harbor, ME)
were injected i.p. with 0.2 ml ascites (2U106 cells) of
murine ovarian carcinoma (MOT) (Dr. F.M. Sirot-
Fig. 2. The e¡ect of j of liposome/DNA complexes on NaCl
concentration, pH and temperature. 30 Wg of CAT plasmid
DNA was mixed with 30^600 nmol of liposomes in water to
give L/D = 1, 10 and 20, at di¡erent NaCl concentrations (A),
pHs (B), or temperatures (C) and subject to j measurement.
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nak, Memorial Sloan Kettering, New York) using a
22-gauge needle as described [7]. After 4 days, cispla-
tin (7 mg/kg) was injected i.p. into mice. For solid
tumors, MOT ascites or SKBR3 human breast car-
cinoma (ATCC) (8U106 cells/0.1 ml) grown in
RPMI 1640 supplemented with 10% fetal bovine se-
rum and penicillin and streptomycin were injected
s.c. to 6^7-week-old female athymic nude mice (Har-
lan Sprague Dawley, Indianapolis, IN) using a 25-
gauge needle as described [6]. When the tumor grew
to 8^10 nm, mice were injected i.p. with cisplatin
(5 mg/kg). One week after cisplatin injection, lipo-
some/DNA complexes were directly injected into
the tumors grown in mice. 200 Wg of DNA for ascitic
tumors or 30 Wg of DNA for solid tumors was mixed
with an appropriate amount of DC-chol/DOPE lipo-
somes to give L/D ratios of 1, 10 and 20. After
2 days, the animals were sacri¢ced, the ascitic £uids
or s.c. tumors were taken and processed for the
chloramphenicol acetyltransferase (CAT) assay using
[14C]chloramphenicol as a substrate as described pre-
viously [11].
SKBR3 solid tumors were very poorly transfect-
able with the positively charged complexes formed at
L/D = 10 and 20 but signi¢cantly transfected with the
negatively charged ones at L/D = 1: the CAT activity
of SKBR3 tumors without and with cisplatin pre-
treatment was 11.9 þ 5.1% and 24.7 þ 4.4%, respec-
tively (Table 1). MOT tumors were very poorly
transfectable with the complexes formed at any ratio
without pre-injection of cisplatin [7]. Cisplatin-sensi-
tized MOT s.c. tumors were signi¢cantly transfect-
able with the complexes formed at L/D = 1 only
(CAT activity = 10.9 þ 3.1%) (Table 1). In contrast,
cisplatin-sensitized MOT ascitic tumors were signi¢-
cantly transfectable with the complexes formed at all
three ratios where higher gene transfer e⁄ciency was
observed with the positively charged ones (L/D = 10
and 20) (Table 1). This slightly lower gene transfer
e⁄ciency of the negatively charged complexes can be
as e⁄cient as the positively charged ones when the
injection is repeated (at least two injections), which is
the most common case for therapy regimes. These
results indicate that the negatively charged complex
also e⁄ciently delivered DNA to both solid and as-
citic tumor cells. This is a very important ¢nding
Table 1
j, dH and in situ lipofection activities of liposome/DNA complexes formed in water
L/D = 1 L/D = 10 L/D = 20
Final concentration
DNA (Wg/Wl) 0.167 0.167 0.167
Liposomes (nmol/Wl) 0.167 1.67 3.33
j (mV)a 358.1 þ 2.1 +8.44 þ 3.7 +24.3 þ 3.6
CAT activity (% conversion)b
SKBR3 solid tumors
(intratumor injection)
24.7 þ 4.4 (11.9 þ 5.1)c 2.6 þ 3.3 (3.1 þ 2.7)c 5.1 þ 6.2 (4.3 þ 5.5)c
MOT solid tumors
(intratumor injection)
10.9 þ 3.1 0.5 þ 0.9 0.6 þ 0.4
MOT ascitic tumors
(single i.p. injection)
44.2 þ 6.2 59.9 þ 7.3 55.1 þ 4.6
MOT ascitic tumors
(multiple i.p. injection)
62.5 þ 3.7 63.3 þ 4.4 60.8 þ 5.3
dH (nm)a 218 þ 4.7 408 þ 23 418 þ 19
Physical stabilityd stable aggregatione precipitation aggregatione precipitation
30 Wg of CAT DNA for solid tumors or 200 Wg of CAT DNA for ascitic tumors was mixed with 30^4000 nmol of DC-chol liposomes
to give L/D ratios of 1, 10 and 20 in water. The complexes were injected directly into the tumors implanted s.c. or i.p. and grown in
mice for CAT gene expression following cisplatin injection or subjected to j and dH measurements.
aNo NaCl added at 25‡C.
bAcetylated forms divided by acetylated plus non-acetylated forms after separation on TLC and quanti¢cation by Phosphorimager.
cCAT activity of SKBR3 solid tumors in the absence of cisplatin treatment.
dChanges in physical appearance of a formulation.
eThe complexes were injected immediately after mixing to minimize aggregation or precipitation.
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because it is known that the positively charged com-
plexes deliver DNA more e⁄ciently inside the cells,
which is not the case for solid tumors. Therefore, it
seems reasonable for one to inject the complexes
formed at any ratio between 1 and 20 to treat ascitic
tumors, regardless of the complex charge, size or
stability, taking into consideration, however, that at
higher ratios the complexes are unstable and more
toxic. Further, MOT solid tumors were approxi-
mately two-fold less transfectable than MOT ascitic
tumors (Table 1). This is because (i) the solid tumor
microenvironment is di¡erent from ascitic tumors
[12,13] and (ii) cisplatin injected i.p. which was
used to facilitate gene transfer is in direct contact
with ascitic tumor cells [14]. Our studies suggest
that the development of a new formulation or the
synthesis of new lipids or non-lipids for improving
gene transfer e⁄ciency to solid tumors should be
di¡erent from ascitic-like tumors.
In conclusion, the cationic liposomes and DNA
complexes formed at a low liposome/DNA ratio
(L/D = 1) in water were stable and negatively
charged, which e⁄ciently delivered DNA to both
solid and ascitic tumors. In spite of a number of
reports on the dependence of e⁄cient in vitro and
in vivo gene delivery on positive charges of trans-
fection complexes, our data showed that the posi-
tively charged complexes were very poor in delivering
DNA into solid s.c. tumors, although they were
somewhat more e⁄cient than the negatively charged
ones to deliver DNA into ascitic tumors grown in the
peritoneum regardless of complex size or stability.
Supported by Rutgers Busch Biomedical Fund and
NIH R29CA75249.
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